目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global anti-obesity drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global anti-obesity drugs market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Drug class Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Class III anti-obesity drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Class III anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Class III anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Class III anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Class III anti-obesity drugs - Year-over-year growth 2022-2027 (%)
6.4 Class II anti-obesity drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Class II anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Class II anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Class II anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Class II anti-obesity drugs - Year-over-year growth 2022-2027 (%)
6.5 Class I anti-obesity drugs - Market size and forecast 2022-2027
Exhibit 42: Chart on Class I anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Class I anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Class I anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Class I anti-obesity drugs - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)

7 Market Segmentation by Drug Class
7.1 Market segments
Exhibit 47: Chart on Drug Class - Market share 2022-2027 (%)
Exhibit 48: Data Table on Drug Class - Market share 2022-2027 (%)
7.2 Comparison by Drug Class
Exhibit 49: Chart on Comparison by Drug Class
Exhibit 50: Data Table on Comparison by Drug Class
7.3 Peripherally acting drugs - Market size and forecast 2022-2027
Exhibit 51: Chart on Peripherally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Peripherally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Peripherally acting drugs - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Peripherally acting drugs - Year-over-year growth 2022-2027 (%)
7.4 Centrally acting drugs - Market size and forecast 2022-2027
Exhibit 55: Chart on Centrally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Centrally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Centrally acting drugs - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Centrally acting drugs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Drug Class
Exhibit 59: Market opportunity by Drug Class ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Alvogen Iceland ehf
Exhibit 108: Alvogen Iceland ehf - Overview
Exhibit 109: Alvogen Iceland ehf - Product / Service
Exhibit 110: Alvogen Iceland ehf - Key offerings
12.4 AstraZeneca
Exhibit 111: AstraZeneca - Overview
Exhibit 112: AstraZeneca - Product / Service
Exhibit 113: AstraZeneca - Key news
Exhibit 114: AstraZeneca - Key offerings
12.5 Boehringer Ingelheim International GmbH
Exhibit 115: Boehringer Ingelheim International GmbH - Overview
Exhibit 116: Boehringer Ingelheim International GmbH - Business segments
Exhibit 117: Boehringer Ingelheim International GmbH - Key news
Exhibit 118: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 119: Boehringer Ingelheim International GmbH - Segment focus
12.6 Cadila Healthcare Ltd.
Exhibit 120: Cadila Healthcare Ltd. - Overview
Exhibit 121: Cadila Healthcare Ltd. - Business segments
Exhibit 122: Cadila Healthcare Ltd. - Key news
Exhibit 123: Cadila Healthcare Ltd. - Key offerings
Exhibit 124: Cadila Healthcare Ltd. - Segment focus
12.7 Eli Lilly and Co.
Exhibit 125: Eli Lilly and Co. - Overview
Exhibit 126: Eli Lilly and Co. - Product / Service
Exhibit 127: Eli Lilly and Co. - Key offerings
12.8 Empros Pharma AB
Exhibit 128: Empros Pharma AB - Overview
Exhibit 129: Empros Pharma AB - Product / Service
Exhibit 130: Empros Pharma AB - Key offerings
12.9 ERX Pharmaceuticals Inc.
Exhibit 131: ERX Pharmaceuticals Inc. - Overview
Exhibit 132: ERX Pharmaceuticals Inc. - Product / Service
Exhibit 133: ERX Pharmaceuticals Inc. - Key offerings
12.10 Gelesis Inc.
Exhibit 134: Gelesis Inc. - Overview
Exhibit 135: Gelesis Inc. - Product / Service
Exhibit 136: Gelesis Inc. - Key news
Exhibit 137: Gelesis Inc. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 138: GlaxoSmithKline Plc - Overview
Exhibit 139: GlaxoSmithKline Plc - Business segments
Exhibit 140: GlaxoSmithKline Plc - Key offerings
Exhibit 141: GlaxoSmithKline Plc - Segment focus
12.12 Innovent Biologics Ltd.
Exhibit 142: Innovent Biologics Ltd. - Overview
Exhibit 143: Innovent Biologics Ltd. - Product / Service
Exhibit 144: Innovent Biologics Ltd. - Key offerings
12.13 LG Chem
Exhibit 145: LG Chem - Overview
Exhibit 146: LG Chem - Business segments
Exhibit 147: LG Chem - Key news
Exhibit 148: LG Chem - Key offerings
Exhibit 149: LG Chem - Segment focus
12.14 Novo Nordisk AS
Exhibit 150: Novo Nordisk AS - Overview
Exhibit 151: Novo Nordisk AS - Business segments
Exhibit 152: Novo Nordisk AS - Key offerings
Exhibit 153: Novo Nordisk AS - Segment focus
12.15 Rhythm Pharmaceuticals Inc.
Exhibit 154: Rhythm Pharmaceuticals Inc. - Overview
Exhibit 155: Rhythm Pharmaceuticals Inc. - Product / Service
Exhibit 156: Rhythm Pharmaceuticals Inc. - Key offerings
12.16 SCOHIA PHARMA Inc.
Exhibit 157: SCOHIA PHARMA Inc. - Overview
Exhibit 158: SCOHIA PHARMA Inc. - Product / Service
Exhibit 159: SCOHIA PHARMA Inc. - Key news
Exhibit 160: SCOHIA PHARMA Inc. - Key offerings
12.17 VIVUS LLC
Exhibit 161: VIVUS LLC - Overview
Exhibit 162: VIVUS LLC - Product / Service
Exhibit 163: VIVUS LLC - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global anti-obesity drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Class III anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Class III anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Class III anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Class III anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Class II anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Class II anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Class II anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Class II anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Class I anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Class I anti-obesity drugs - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Class I anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Class I anti-obesity drugs - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits48: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Drug Class
Exhibits50: Data Table on Comparison by Drug Class
Exhibits51: Chart on Peripherally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Peripherally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Peripherally acting drugs - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Peripherally acting drugs - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Centrally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Centrally acting drugs - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Centrally acting drugs - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Centrally acting drugs - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Drug Class ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Alvogen Iceland ehf - Overview
Exhibits109: Alvogen Iceland ehf - Product / Service
Exhibits110: Alvogen Iceland ehf - Key offerings
Exhibits111: AstraZeneca - Overview
Exhibits112: AstraZeneca - Product / Service
Exhibits113: AstraZeneca - Key news
Exhibits114: AstraZeneca - Key offerings
Exhibits115: Boehringer Ingelheim International GmbH - Overview
Exhibits116: Boehringer Ingelheim International GmbH - Business segments
Exhibits117: Boehringer Ingelheim International GmbH - Key news
Exhibits118: Boehringer Ingelheim International GmbH - Key offerings
Exhibits119: Boehringer Ingelheim International GmbH - Segment focus
Exhibits120: Cadila Healthcare Ltd. - Overview
Exhibits121: Cadila Healthcare Ltd. - Business segments
Exhibits122: Cadila Healthcare Ltd. - Key news
Exhibits123: Cadila Healthcare Ltd. - Key offerings
Exhibits124: Cadila Healthcare Ltd. - Segment focus
Exhibits125: Eli Lilly and Co. - Overview
Exhibits126: Eli Lilly and Co. - Product / Service
Exhibits127: Eli Lilly and Co. - Key offerings
Exhibits128: Empros Pharma AB - Overview
Exhibits129: Empros Pharma AB - Product / Service
Exhibits130: Empros Pharma AB - Key offerings
Exhibits131: ERX Pharmaceuticals Inc. - Overview
Exhibits132: ERX Pharmaceuticals Inc. - Product / Service
Exhibits133: ERX Pharmaceuticals Inc. - Key offerings
Exhibits134: Gelesis Inc. - Overview
Exhibits135: Gelesis Inc. - Product / Service
Exhibits136: Gelesis Inc. - Key news
Exhibits137: Gelesis Inc. - Key offerings
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key offerings
Exhibits141: GlaxoSmithKline Plc - Segment focus
Exhibits142: Innovent Biologics Ltd. - Overview
Exhibits143: Innovent Biologics Ltd. - Product / Service
Exhibits144: Innovent Biologics Ltd. - Key offerings
Exhibits145: LG Chem - Overview
Exhibits146: LG Chem - Business segments
Exhibits147: LG Chem - Key news
Exhibits148: LG Chem - Key offerings
Exhibits149: LG Chem - Segment focus
Exhibits150: Novo Nordisk AS - Overview
Exhibits151: Novo Nordisk AS - Business segments
Exhibits152: Novo Nordisk AS - Key offerings
Exhibits153: Novo Nordisk AS - Segment focus
Exhibits154: Rhythm Pharmaceuticals Inc. - Overview
Exhibits155: Rhythm Pharmaceuticals Inc. - Product / Service
Exhibits156: Rhythm Pharmaceuticals Inc. - Key offerings
Exhibits157: SCOHIA PHARMA Inc. - Overview
Exhibits158: SCOHIA PHARMA Inc. - Product / Service
Exhibits159: SCOHIA PHARMA Inc. - Key news
Exhibits160: SCOHIA PHARMA Inc. - Key offerings
Exhibits161: VIVUS LLC - Overview
Exhibits162: VIVUS LLC - Product / Service
Exhibits163: VIVUS LLC - Key offerings
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations